Andrew Dodson

8PUBLICATIONS
30CO-AUTHORS
Predictive and prognostic markersMedical infection agents (incl. prions)Formal methods for softwareLiquid biopsiesGenomics and transcriptomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 18, 2026
UK recommendations for Ki-67 immunohistochemical staining and interpretation in breast cancer.

|May 19, 2026
UK participation in the UK National External Quality Assessment Scheme for mismatch repair immunohistochemistry: insights from the last decade.

|Oct 17, 2025
Inter-rater agreement of HER2-low scores between expert breast pathologists and the Visiopharm digital image analysis application (HER2 APP, CE2797).

Suzanne Parry, Lila Zabaglo, Abeer M Shaaban

|Oct 14, 2021
Biomarkers of Response and Resistance to Palbociclib Plus Letrozole in Patients With ER+/HER2- Breast Cancer.

Mitch Dowsett, Lucy Kilburn, Mothaffar F Rimawi

|Dec 28, 2020
Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working Group.

Torsten O Nielsen, Samuel C Y Leung, David L Rimm

|Dec 19, 2019
External quality assessment demonstrates that PD-L1 22C3 and SP263 assays are systematically different.

Andrew Dodson, Suzanne Parry, Birgit Lissenberg-Witte

Pageof 2

Frequent Collaborators

1 joint publications

Torsten O Nielsen

1 joint publications

Samuel C Y Leung

1 joint publications

David L Rimm

1 joint publications

Balazs Acs